Tekla Life Sciences Investors
HQL · NYSE
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $17 | $15 | $0 | $0 |
| Receivables | $0 | $5 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | -$15 | $0 | -$0 |
| Total Curr. Assets | $0 | $5 | $1 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $460 | $398 | $414 | $534 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $0 | $0 | $0 |
| Total NC Assets | $474 | $398 | $414 | $534 |
| Other Assets | -$14 | $0 | $0 | $0 |
| Total Assets | $461 | $403 | $415 | $534 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $5 | $0 |
| Short-Term Debt | $0 | $0 | $11 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $5 | $0 |
| Other Curr. Liab. | $1 | $0 | -$16 | $1 |
| Total Curr. Liab. | $1 | $0 | $5 | $11 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $12 | $11 |
| Total NC Liab. | $1 | $1 | $12 | $11 |
| Other Liabilities | $1 | $0 | $7 | -$9 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1 | $1 | $17 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $44 | -$1 | $10 | $151 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $415 | $403 | $388 | $372 |
| Total Equity | $460 | $402 | $398 | $523 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $461 | $403 | $415 | $534 |
| Net Debt | $0 | -$0 | $11 | $10 |